Clinical Trials Directory

Trials / Completed

CompletedNCT02048098

Misoprostol for Second Trimester Termination of Pregnancy

A Comparison Between Vaginal Misoprostol vs. Buccal Misoprostol For Second Trimester Termination of Pregnancy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
Female
Age
16 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the efficacy of 400 µg vaginal misoprostol per 3 hours to 400 µg buccal misoprostol per 3 hours in second trimester termination of viable pregnancy

Conditions

Interventions

TypeNameDescription
DRUGVaginal misoprostol400 µg vaginal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 µg vaginal misoprostol per 3 hours up to 6 doses will be administered. If abortion had not occured in 48 hour after the start of the study it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.
DRUGBuccal misoprostol400 µg buccal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 µg buccal misoprostol per 3 hours up to 6 doses will be administered. If abortion had not occured in 48 hour after the start of the study it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.

Timeline

Start date
2014-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-01-29
Last updated
2015-01-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02048098. Inclusion in this directory is not an endorsement.